Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Ayahuasca
Experience:3-MeO-PCP - Extreme psychosis
4-HO-MET
MDA
4-FA
Bufotenin
Psilocybin mushrooms
Tree.jpgJapanese Garden by Anonymous
JWH-018
Experience:25mg 3-MeO-PCP - Enhanced film experience
DOI
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
3C-E
TMA-6
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Escaline
DOM
2C-H
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Experience:1000 Morning Glory seeds - Rediscovering the Self
4-HO-DET
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
Experience:25mg Deschloroketamine - My first time orally dosing DCK
2C-T-7
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
DPT
Efavirenz
4-HO-DiPT
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Piracetam
LSM-775
4-HO-MPT
6-APDB
EPT
3-MeO-PCE
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
4-HO-MiPT
2C-P
25N-NBOMe
MiPT
Oxiracetam
4-HO-DPT
JWH-073
25I-NBOH
Pregabalin
Cannabis
GABAergic hallucinogens
TMA-2
ALD-52
Amanita muscaria
2C-I
Psilocin
Experience:800 seeds LSA - My First Trip Ever
4-AcO-DMT
Chur City in Switzerland.jpgChur, Switzerland by Naps284
1P-LSD
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
2C-D
PRO-LAD
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
THJ-2201
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Aniracetam
Coluracetam
25B-NBOH
25C-NBOH
AL-LAD
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
1P-ETH-LAD
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
2C-T-2
Phenylpiracetam
4-HO-EPT
Mescaline
Experience:40mg - Brothermind and the Forest's Hand
Experience:1mg 25c-NBOMe - Experiment in my room
5-MeO-DiPT
Allylescaline
Enhancement of colour rose.jpgRose by Chelsea Morgan
Selective serotonin reuptake inhibitor
1B-LSD
2C-B-FLY
4-AcO-DiPT
25I-NBOMe
DiPT
4-AcO-MiPT
5-MeO-DiBF
5F-PB-22
DMT
DET
Experience:2 tabs DOB - My DOB Nightmare
Experience:300µg LSD - Togetherness and the Silent Dusk
2C-C
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Experience:BK-2C-B - Various experiences
Bromo-DragonFLY
MDEA
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
LSD
Experience:250mg DXM - DXM Itch and Trip Report
Chameleon.jpgChameleon by Anonymous.
5-Hydroxytryptophan
25C-NBOMe
4-AcO-MET
Proscaline
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
MPT
3-MMC
LSA
Omberacetam
Experience:4-HO-MiPT / A care free psychedelic getaway
DOB
THJ-018
25B-NBOMe
2C-T-21
Ibogaine
Experience:4-AcO-DMT + 200mg Pill
ETH-LAD
ΑMT
2C-B
Experience:4x 200ug tabs - You do not need to understand
6-APB
Paradise island by Xanny.jpgParadise island by Subsentience
MET
Methallylescaline
MDMA
Pramiracetam
LSZ
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
4-AcO-DET
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
25D-NBOMe
Experience:120mg - Garden of The Gods
PARGY-LAD
Phenethylamine (compound)
MiPLA
5-MeO-DALT
2C-E
Memantine
5-MeO-MiPT
MDAI
Experience:337mg DMT fumarate - A Day With DMT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Βk-2C-B
DOC

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.